“Alterations In The Human Plasma Lipidome In Response To Tularemia Vaccination.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030414. https://pubmed.ncbi.nlm.nih.gov/32722213/.
. 2020. “Cytomegalovirus Genetic Diversity Following Primary Infection.”. J Infect Dis 221 (5). J Infect Dis: 715-720. doi:10.1093/infdis/jiz507.
. 2020. “Flagellin Adjuvanted F1/v Subunit Plague Vaccine Induces T Cell And Functional Antibody Responses With Unique Gene Signatures.”. Npj Vaccines 5. Npj Vaccines: 6. doi:10.1038/s41541-020-0156-y.
. 2020. “Plasmablast, Memory B Cell, Cd4+ T Cell, And Circulating Follicular Helper T Cell Responses To A Non-Replicating Modified Vaccinia Ankara Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010069.
. 2020. “Proteomic Analysis Of Human Immune Responses To Live-Attenuated Tularemia Vaccine.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030413. https://pubmed.ncbi.nlm.nih.gov/32722207/.
. 2020. “Transcriptomic And Metabolic Responses To A Live-Attenuated Vaccine.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030412. https://pubmed.ncbi.nlm.nih.gov/32722194/.
. 2020. “As03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures In Human Peripheral Blood Mononuclear Cells.”. J Infect Dis 219 (11). J Infect Dis: 1786-1798. doi:10.1093/infdis/jiy721.
. 2019. “Systems Vaccinology For A Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral And Cellular Immune Responses.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010004.
. 2019. “Cell-Based Systems Biology Analysis Of Human As03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.”. Plos One 12 (1). Plos One: e0167488. doi:10.1371/journal.pone.0167488.
. 2017. “Molecular Evolution Of Herpes Simplex Virus 2 Complete Genomes: Comparison Between Primary And Recurrent Infections.”. J Virol 91 (23). J Virol. doi:10.1128/JVI.00942-17.
. 2017. “Proteomics Show Antigen Presentation Processes In Human Immune Cells After As03-H5N1 Vaccination.”. Proteomics 17 (12). Proteomics. doi:10.1002/pmic.201600453.
. 2017. “Rseqrep: Rna-Seq Reports, An Open-Source Cloud-Enabled Framework For Reproducible Rna-Seq Data Processing, Analysis, And Result Reporting.”. F1000Res 6. F1000Res: 2162. doi:10.12688/f1000research.13049.2.
. 2017. “Safety And Immunogenicity Of A Modified Vaccinia Ankara Vaccine Using Three Immunization Schedules And Two Modes Of Delivery: A Randomized Clinical Non-Inferiority Trial.”. Vaccine 35 (13). Vaccine: 1675-1682. doi:10.1016/j.vaccine.2017.02.032.
. 2017. “Tularemia Vaccine: Safety, Reactogenicity, "take" Skin Reactions, And Antibody Responses Following Vaccination With A New Lot Of The Francisella Tularensis Live Vaccine Strain - A Phase 2 Randomized Clinical Trial.”. Vaccine 35 (36). Vaccine: 4730-4737. doi:10.1016/j.vaccine.2017.07.024.
. 2017. “Cell Mediated Immune Responses Following Revaccination With An Influenza A/h5N1 Vaccine.”. Vaccine 34 (4). Vaccine: 547-554. doi:10.1016/j.vaccine.2015.11.055.
. 2016. “Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases The Duration Of T Cell Responses Induced By A Heterologous H5 Booster Vaccination.”. J Infect Dis 214 (7). J Infect Dis: 1020-9. doi:10.1093/infdis/jiw310.
. 2016. “Comparison Of Lyophilized Versus Liquid Modified Vaccinia Ankara (Mva) Formulations And Subcutaneous Versus Intradermal Routes Of Administration In Healthy Vaccinia-Naïve Subjects.”. Vaccine 33 (39). Vaccine: 5225-34. doi:10.1016/j.vaccine.2015.06.075.
. 2015. “Immunogenicity And Safety Of Four Different Dosing Regimens Of Anthrax Vaccine Adsorbed For Post-Exposure Prophylaxis For Anthrax In Adults.”. Vaccine 32 (47). Vaccine: 6284-93. doi:10.1016/j.vaccine.2014.08.076.
. 2014. “Phase Ii Randomized, Double-Blinded Comparison Of A Single High Dose (5×10(8) Tcid50) Of Modified Vaccinia Ankara Compared To A Standard Dose (1×10(8) Tcid50) In Healthy Vaccinia-Naïve Individuals.”. Vaccine 32 (23). Vaccine: 2732-9. doi:10.1016/j.vaccine.2014.02.043.
. 2014. “Safety And Immunogenicity Of Tetanus Diphtheria And Acellular Pertussis (Tdap) Immunization During Pregnancy In Mothers And Infants: A Randomized Clinical Trial.”. Jama 311 (17). Jama: 1760-9. doi:10.1001/jama.2014.3633.
. 2014.